Literature DB >> 15796960

Genetic analysis of susceptibility to endometrial adenocarcinoma in the BDII rat model.

L Roshani1, P Mallon, E Sjostrand, D Wedekind, J Szpirer, C Szpirer, H J Hedrich, K Klinga-Levan.   

Abstract

Most cancers are genetically complex and heterogeneous, a serious obstacle to identifying specific genes underlying the disease. If inbred animal models are used, then both the genetic constitution and environmental influences can be carefully controlled. Females of the BDII inbred rat strain are genetically predisposed to endometrial cancer; more than 90% of virgin BDII females will develop endometrial adenocarcinoma (EAC) during their life span. BDII females were crossed to males from inbred strains with low EAC incidence (SPRD or BN). When F(1) males were backcrossed to BDII females to generate N(1) populations of offspring, about one fourth of the female progeny developed EAC. With transmission disequilibrium test analysis, significant association was detected in three chromosomal regions (on RNO1, RNO11, and RNO17) in the SPRD crosses and in the short arm of RNO20 in the BN crosses. It appears that several susceptibility genes with minor but cooperating effects are responsible for the susceptibility. Furthermore, it seems clear from the interstrain crosses not only that the onset of tumors depends on the presence of susceptibility alleles from the EAC-prone BDII strain, but also that tumor development is affected by the contribution of a genetic component derived from the nonsusceptible strains.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15796960     DOI: 10.1016/j.cancergencyto.2004.08.034

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  8 in total

1.  Genetic identification of distinct loci controlling mammary tumor multiplicity, latency, and aggressiveness in the rat.

Authors:  Xiaojiang Quan; Jean-François Laes; Daniel Stieber; Michèle Rivière; Jose Russo; Dirk Wedekind; Wouter Coppieters; Frédéric Farnir; Michel Georges; Josiane Szpirer; Claude Szpirer
Journal:  Mamm Genome       Date:  2006-04-04       Impact factor: 2.957

Review 2.  Mammary cancer susceptibility: human genes and rodent models.

Authors:  Claude Szpirer; Josiane Szpirer
Journal:  Mamm Genome       Date:  2007-12-01       Impact factor: 2.957

3.  SKY analysis revealed recurrent numerical and structural chromosome changes in BDII rat endometrial carcinomas.

Authors:  Eva Falck; Carola Hedberg; Karin Klinga-Levan; Afrouz Behboudi
Journal:  Cancer Cell Int       Date:  2011-06-27       Impact factor: 5.722

4.  Analysis of an independent tumor suppressor locus telomeric to Tp53 suggested Inpp5k and Myo1c as novel tumor suppressor gene candidates in this region.

Authors:  Carola Hedberg Oldfors; Diego Garcia Dios; Anna Linder; Kittichate Visuttijai; Emma Samuelson; Sandra Karlsson; Staffan Nilsson; Afrouz Behboudi
Journal:  BMC Genet       Date:  2015-07-14       Impact factor: 2.797

Review 5.  Modeling Endometrial Cancer: Past, Present, and Future.

Authors:  Tom Van Nyen; Cristian P Moiola; Eva Colas; Daniela Annibali; Frédéric Amant
Journal:  Int J Mol Sci       Date:  2018-08-09       Impact factor: 5.923

6.  Gene expression profiling predicts a three-gene expression signature of endometrial adenocarcinoma in a rat model.

Authors:  Sandra Karlsson; Björn Olsson; Karin Klinga-Levan
Journal:  Cancer Cell Int       Date:  2009-05-08       Impact factor: 5.722

7.  Expression patterns of Phf5a/PHF5A and Gja1/GJA1 in rat and human endometrial cancer.

Authors:  Eva Falck; Karin Klinga-Levan
Journal:  Cancer Cell Int       Date:  2013-05-15       Impact factor: 5.722

8.  Validation of suitable endogenous control genes for quantitative PCR analysis of microRNA gene expression in a rat model of endometrial cancer.

Authors:  Sanja Jurcevic; Björn Olsson; Karin Klinga-Levan
Journal:  Cancer Cell Int       Date:  2013-05-16       Impact factor: 5.722

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.